Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Glaucoma
•
Uveitis and Ocular Immunology
When would you consider using selective laser trabeculoplasty (SLT) for managing uveitic glaucoma?
Related Questions
How do you manage cystoid macular edema (CME) in patients with steroid-induced intraocular hypertension that is resistant to topical treatments?
How do you manage checkpoint inhibitor-associated Vogt-Koyanagi-Harada (VKH) disease in patients who have poorly controlled diabetes?
How do you approach the management of bilateral non-infectious uveitis in the pediatric population?
How would you approach management of nodular scleritis in the setting of suspected GCA?
Do you routinely recommend IV systemic antibiotic therapy in additional to intravitreal antibiotic therapy for exogenous bacterial endophthalmitis?
How do you manage Cancer-Associated Retinopathy (CAR) in a patient who doesn’t have a known cancer diagnosis, given the difficulty in finding the underlying cancer and the risks of using immunosuppressive treatments to preserve vision?
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
How do you decide where to place the LPI for angle-closure glaucoma?
In a patient with isolated HLA B27+ anterior uveitis, how long would you continue immunosuppressive therapy?
Which MIGS procedure do you believe provides the most sustainable IOP reduction when performed alongside cataract surgery?
